Daily non-political popular news in brief.

Conflicting attitudes hinder participation in clinical trials

02-01-2007 · EurekAlert!

Women have conflicting attitudes about participating in clinical trials because of uncertainties about trusting the experimenters, fear of the trial itself and hope that the research will result in medical progress, according to a new study at Wake Forest University School of Medicine.

Keywords: conflicting, attitudes, hinder, participation, clinical, trials, attitude, trial

« Previous | Next »

Similar news on "Conflicting attitudes hinder participation in clinical trials":

The Lancet publishes details on two studies of adult male circumcision to prevent HIV
02-22-2007 · EurekAlert!
Two papers in the February 24 issue of The Lancet provide detailed analyses of two NIAID-funded clinical trials of adult male circumcision in Kenya and Uganda. In the trial of 2,784 HIV-negative men in Kisumu, Kenya, the investigators found the rate of HIV acquisition in circumcised men to be 53 percent lower than in uncircumcised men. Investigators in the trial of 4,996 HIV-negative men in Rakai, Uganda, report that HIV acquisition was reduced by 51 percent in circumcised men.
Similar news · Read more »
New agreement questions NHS relation with industry
11-16-2006 · EurekAlert!
The Department of Health's new clinical trials agreement raises questions about the NHS's relation with the drug industry, says an editorial published in BMJ Online today.Following the tragedy of the TGN1412 trial, the Department of Health announced last month that a model clinical trials agreement has been finalised. This provides a template that can be used by all NHS trusts for any clinical trial, without modification.
Similar news · Read more »
Clinical trial coordinators need more financial conflict-of-interest training
04-22-2007 · EurekAlert!
Medical professionals conducting clinical trials should provide more information about financial conflicts of interest before they talk to patients about participating in the trials.
Similar news · Read more »
ADAPT safety results now published
11-16-2006 · EurekAlert!
A paper appearing this week in the Public Library of Science journal PLoS Clinical Trials presents findings from a large National Institutes of Health sponsored trial regarding the cardiovascular and cerebrovascular safety of two non-steroidal anti-inflammatory drugs, celecoxib and naproxen. The trial was initially conducted to test whether these drugs might prevent or delay the onset of Alzheimer's disease.
Similar news · Read more »
Phase III trials of cellulose sulfate microbicide for HIV prevention closed
01-31-2007 · EurekAlert!
CONRAD, a reproductive health research organization, announced today that it has halted a Phase III clinical trial of cellulose sulfate -- a topical microbicide gel being tested for HIV prevention in women -- because preliminary results indicated that cellulose sulfate could lead to an increased risk of HIV infection in women who use the compound. The trial was being conducted in South Africa, Benin, Uganda, and India.
Similar news · Read more »
Minimally invasive device shows promise in treating female urinary incontinence
05-22-2007 · EurekAlert!
A minimally invasive device for treating recurrent stress urinary incontinence in women has been shown to be safe and effective in early clinical trials and is now under review by the US Food and Drug Administration (FDA), says Emory University School of Medicine urologist and trial co-principal investigator Niall Galloway, MD.
Similar news · Read more »
Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder
01-31-2008 · EurekAlert!
Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of The Lancet.
Similar news · Read more »
Rutgers biomaterial debuts in clinical trials of new stent
10-18-2007 · EurekAlert!
A revolutionary, new biomaterial, developed at the New Jersey Center for Biomaterials at Rutgers University, has moved from the lab bench to field testing in record time. This achievement, a product of a breakthrough methodology in biomaterials discovery, is the enabling technology behind a coronary stent undergoing its first-in-human clinical trial in Germany and in Brazil.
Similar news · Read more »
Drug based on MGH discovery may significantly improve treatment of dangerous blood disorder
01-31-2008 · EurekAlert!
Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of the Lancet.
Similar news · Read more »
New study suggests promising drug combinations for sleeping sickness
12-08-2006 · EurekAlert!
Results from a clinical trial evaluating new drug combinations for sleeping sickness, carried out by the international humanitarian medical aid agency Medecins Sans Frontieres (MSF), and its research arm, Epicentre, have now been published in the journal PLoS Clinical Trials.
Similar news · Read more »